Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong You

Showing results (881-890 of 904) with videos related to

Pageof 91
Sort By:
Ebiomedicine|July 3, 2015
An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular CarcinomaYu Hong, Jiang Long, Hai Li, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 18, 2013
[Epidemiological study on developmental delay of 18-month-old children from four districts/counties in Beijing]Wen-juan Zhou, Ai-min Liang, Feng-zhi Wang, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jialing Zhou, Lin Wang, et al.
Hepatology (Baltimore, Md.)|August 23, 2023
The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosisXiujuan Chang, Caihong Lv, Bingqiong Wang, et al.
Plos Pathogens|February 15, 2022
Chromosome-level genome of Schistosoma haematobium underpins genome-wide explorations of molecular variationAndreas J Stroehlein, Pasi K Korhonen, V Vern Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related EventsYameng Sun, Wei Chen, Shuyan Chen, et al.
Omics : a Journal of Integrative Biology|June 12, 2020
A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B VirusMin Cong, Xiaojuan Ou, Jian Huang, et al.
Journal of Medical Virology|March 25, 2019
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapyTianhui Liu, Yameng Sun, Jialing Zhou, et al.
Journal of Digestive Diseases|July 24, 2020
Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis BWei Jia Duan, Xiao Zhong Wang, An Lin Ma, et al.
Cell Reports|July 25, 2025
Cryo-EM and cryo-ET reveal the molecular architecture and host interactions of mycobacteriophage DougeJitendra Maharana, Chun-Hsiung Wang, Li-An Tsai, et al.
Pageof 91

Showing results (881-890 of 904) with videos related to

Sort By:
Pageof 91
Ebiomedicine|July 3, 2015
An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular CarcinomaYu Hong, Jiang Long, Hai Li, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 18, 2013
[Epidemiological study on developmental delay of 18-month-old children from four districts/counties in Beijing]Wen-juan Zhou, Ai-min Liang, Feng-zhi Wang, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jialing Zhou, Lin Wang, et al.
Hepatology (Baltimore, Md.)|August 23, 2023
The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosisXiujuan Chang, Caihong Lv, Bingqiong Wang, et al.
Plos Pathogens|February 15, 2022
Chromosome-level genome of Schistosoma haematobium underpins genome-wide explorations of molecular variationAndreas J Stroehlein, Pasi K Korhonen, V Vern Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related EventsYameng Sun, Wei Chen, Shuyan Chen, et al.
Omics : a Journal of Integrative Biology|June 12, 2020
A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B VirusMin Cong, Xiaojuan Ou, Jian Huang, et al.
Journal of Medical Virology|March 25, 2019
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapyTianhui Liu, Yameng Sun, Jialing Zhou, et al.
Journal of Digestive Diseases|July 24, 2020
Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis BWei Jia Duan, Xiao Zhong Wang, An Lin Ma, et al.
Cell Reports|July 25, 2025
Cryo-EM and cryo-ET reveal the molecular architecture and host interactions of mycobacteriophage DougeJitendra Maharana, Chun-Hsiung Wang, Li-An Tsai, et al.
Pageof 91